Grail Says About 400 Patients Incorrectly Informed They May Have Cancer – NBC US NEWS
(Reuters) -Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc, said the letters
Read More